Urgent.News

What's breaking now, across thousands of outlets.

AI

Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO

The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday

Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in AI

CLAUDE.md Sync: Standardizing AI Agent Coding Standards

Originally published at getorquesta.com/blog/claude-md-sync-standardizing-ai-agent-coding-standards I remember the first time a team told me their AI agents were producing code that looked like it…

  • Orquesta introduces CLAUDE.md Sync to standardize AI agent coding standards.
  • CLAUDE.md acts as AI agent configuration file, lacking centralized management previously.
  • Sync modes include Override and Merge to enforce global standards or combine with local files.

More from Thursday 15 October →